Clinical Trials Browser

Locally Advanced or Metastatic Solid Tumors × 1 year × Clear all

NCT06307795 2026-04-17

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT06328439 2026-03-25

A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT07469774 2026-03-13

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT07461181 2026-03-10

A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT07318649 2026-01-06

Phase 2 Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GH21 Capsules Combined With D-1553 Tablets in Subjects With Locally Advanced or Metastatic Solid Tumors With the KRASG12C Mutation

Phase 2 Not yet recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT05012618 2025-12-24

A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Phase 1 Terminated

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT04511845 2025-07-14

A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Phase 1 Active not recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT06349811 2025-06-15

A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT05205109 2025-06-09

A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT05830539 2025-05-02

IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients

Phase 1/2 Completed

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors